Navigation Links
GlycoVaxyn AG Raises CHF 25 Million in Financing Led by Edmond de Rothschild Investment Partners
Date:3/5/2009

"

"Under the leadership of CEO Philippe Dro, GlycoVaxyn has established the solid fundamentals required to raise funding in the current economic downturn," noted Michel Greco, Chairman of GlycoVaxyn. "The company is well financed for the move into clinical trials and as the team continues to deliver on its business strategy, we look forward to the additional support from our new Board member, Gilles."

About GlycoVaxyn

GlycoVaxyn has built a broad portfolio of novel conjugate vaccines against common severe bacterial infections based on its unique, proprietary in-vivo glycosylation platform. With this platform, the company can develop and produce immunogenic glycoproteins in a simplified biological process that circumvents many of the difficulties involved in current methods. The lead conjugate vaccines in development are directed against Shigella dysenteriae, to prevent serious intestinal infections, and against hospital acquired Staphylococcus aureus. GlycoVaxyn also has active programs against N. meningitidis and Group A Streptococcus. GlycoVaxyn, a spin-out of the Swiss Federal Institute of Technology (ETH), is based in Schlieren, near Zurich, Switzerland. For further information, visit http://www.glycovaxyn.com.


'/>"/>
SOURCE GlycoVaxyn AG
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Eiger BioPharmaceuticals Raises $7.1 Million A Round
2. NanoBio Corporation Raises $12 Million in Series B Financing
3. Divergence Raises $11.8 Million in Series C Financing
4. Sigma-Aldrich (Nasdaq: SIAL) Reports Fourth Quarter Diluted EPS of $0.68. Ends 2008 With Record Sales and Earnings and Raises Quarterly Cash Dividend by 11.5%. Provides Outlook for 2009.
5. AMERIGROUP Praises Expansion of State Childrens Health Insurance Program (SCHIP)
6. JMAR Technologies Raises Awareness of BioSentry -- A High Tech Counter to Bioterrorism
7. Anacor Raises $50 Million in Equity Financing
8. MichBio Expo Draws Nearly 500 Professionals; Career Day Raises Profile
9. Sensorin Raises Equity Financing to Launch Novel Industrial Sensing Venture
10. Simbionix Raises Largest Amount in Companys History in Venture Capital to Accelerate Growth
11. Vista Partners Updates Coverage on Arana Therapeutics (ASX: AAH; AIM: AAHx), Raises Target Price to AU$1.65
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... COLUMBIA, Mo. From cell phones to cars ... everyday life. Scientists and technology companies constantly are ... Now, for the first time using a water-based ... created a long-lasting and more efficient nuclear battery ... as a reliable energy source in automobiles and ...
(Date:9/16/2014)... MILLBROOK, N.Y. , Sept. 16, 2014  Donald Fresne, ... the appointment of Stephan Vagner , PhD to its ... the University of Toulouse, France , performed ... Germany , and at Inserm, the French institute of ... Inserm and works both at the Curie Institute, Orsay, ...
(Date:9/16/2014)... September 16, 2014 Pharma ... to position themselves for their 89th year ... and encoding, Pharma Packaging Solutions is preparing ... and software and new procedures. Establishing training ... Manufacturing Practices (cGMP), Pharma Packaging Solutions will ...
(Date:9/16/2014)... Denmark , Sept. 16, 2014  Ascendis ... innovative TransCon technology to address significant unmet medical ... ongoing Phase 2 pediatric study to evaluate once-weekly ... deficiency, or GHD.  The full interim results will ... the GRS and IGF Society, being held October ...
Breaking Biology Technology:New Appointment to the Scientific Advisory Committee at Egenix, Inc. 2Adding Serialization Capabilities and Expanded Capacity, Pharma Packaging Solutions Is Preparing for 89th Year of Business 2Ascendis Pharma A/S Announces Positive Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4
... and STATE COLLEGE, Pennsylvania, May 9, 2012 ... and SoftGenetics announced today that the two firms ... provide users of 454 Sequencing Systems the broad ... by SoftGenetics NextGENe® software. NextGENe® software ...
... 2012 Phalanx Biotech Group, a global genomic ... of manufacturing and testing for a proprietary targeted ... postnatal detection of microdeletions and microduplications related to ... intellectual delay disorders. Cyto OneArray ® ...
... Nev., May 8, 2012 PDL BioPharma, Inc. (PDL) (NASDAQ: ... the company,s president and chief executive officer, is scheduled to ... http://photos.prnewswire.com/prnh/20110822/SF55808LOGO ) Eleventh Annual JMP Securities Research ... Francisco, CA Goldman Sachs 33rd Annual Global ...
Cached Biology Technology:Roche 454 Life Sciences and SoftGenetics Sign Co-Promotion Agreement for Next-Gen Sequencing Software Tools 2Roche 454 Life Sciences and SoftGenetics Sign Co-Promotion Agreement for Next-Gen Sequencing Software Tools 3Phalanx Biotech Group Announces CytoOneArray®, a Targeted Chromosomal Microarray 2
(Date:9/17/2014)... and MSSA could be curbed by coating hospital ... surface of shark skin, according to research published ... and Infection Control . , The study modelled ... human disease bacteria through touching, sneezes or spillages. ... ridges formulated to resemble shark skin. The study ...
(Date:9/16/2014)... Columbia Center for Children,s Environmental Health at the Mailman ... an association between childhood asthma and prenatal exposure to ... products. Results appear online in the journal Environmental ... exposed during pregnancy to higher levels of the chemicals, ... 72 percent and 78 percent increase in risk of ...
(Date:9/16/2014)... of severe maternal morbidity amongst women in Australia ... new study published today (17 September) in ... . , Australians generally enjoy high standards of ... disparities exist, in particular between indigenous and non ... explore the independent impact of socioeconomic position on ...
Breaking Biology News(10 mins):Sharks' skin has teeth in the fight against hospital superbugs 2Phthalates heighten risk for childhood asthma 2Phthalates heighten risk for childhood asthma 3New study examines the impact of socioeconomic position & maternal morbidity in Australia 2New study examines the impact of socioeconomic position & maternal morbidity in Australia 3
... (BUSM) and Veterans Affairs (VA) Boston Healthcare System have identified ... findings, published online in Molecular Psychiatry , indicate that ... cells from the damaging effects of stress may also be ... reports the first positive results of a genome-wide association study ...
... A top national award for promising research scientists ... assistant professor of biology at Rutgers UniversityCamden. Yakoby ... Science Foundation. The five-year, $686,544 award, which is ... of the project, supports the RutgersCamden researcher,s project "Dynamics ...
... for plants but also for all living organisms. In ... growing shortage of this essential mineral, and the price ... therefore high time to start looking for alternatives. This ... replaced by any other substance. But researchers at the ...
Cached Biology News:BUSM/VA Boston Healthcare System investigators identify new gene linked to PTSD 2Rutgers-Camden genetics researcher receives NSF CAREER Award 2Using wastewater as fertilizer 2Using wastewater as fertilizer 3
Self Closing Forceps...
... cells right in your 35mm dish ... dish Perfusion Chamber has separate openings ... dampen the fluctuations of the liquid ... prevent bubbles from entering the chamber. ...
... cells (BTI-TN-5B1-4) derived from Trichoplusia ni ... to be capable of expressing significantly ... compared to other insect cells. High ... doubling time as adherent cultures- Quick adaptation ...
... steadylite plus assay system offers ... sensitivity, Designed for batch-processing systems, ... higher density microplates such as ... free, Convenient storage conditions ( ...
Biology Products: